Hosted on MSN1mon
US FDA revokes authorization for four COVID antibody drugsthe FDA said in letters dated earlier this month and posted on its website on Monday. The FDA revoked the authorization for Lilly's bebtelovimab, AstraZeneca's Evusheld, GSK's sotrovimab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback